BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21640149)

  • 1. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.
    Tagami T; May JP; Ernsting MJ; Li SD
    J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
    Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
    J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current update of a thermosensitive liposomes composed of DPPC and Brij78.
    Ho L; Bokharaei M; Li SD
    J Drug Target; 2018; 26(5-6):407-419. PubMed ID: 29325469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Materials characterization of the low temperature sensitive liposome (LTSL): effects of the lipid composition (lysolipid and DSPE-PEG2000) on the thermal transition and release of doxorubicin.
    Needham D; Park JY; Wright AM; Tong J
    Faraday Discuss; 2013; 161():515-34; discussion 563-89. PubMed ID: 23805756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
    Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
    J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration.
    Tagami T; Kubota M; Ozeki T
    J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
    Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
    J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo.
    Banno B; Ickenstein LM; Chiu GN; Bally MB; Thewalt J; Brief E; Wasan EK
    J Pharm Sci; 2010 May; 99(5):2295-308. PubMed ID: 19902527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes upon Mild Hyperthermia in C26 Tumor Bearing BALB/c Mice.
    Alavizadeh SH; Gheybi F; Nikpoor AR; Badiee A; Golmohammadzadeh S; Jaafari MR
    Mol Pharm; 2017 Mar; 14(3):712-721. PubMed ID: 28135098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
    Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
    Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
    J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
    Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
    Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant.
    Song H; Zhang J; Liu X; Deng T; Yao P; Zhou S; Yan W
    Pharm Dev Technol; 2016 Sep; 21(6):680-7. PubMed ID: 25975585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
    Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
    Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.